Since disproportionate weight will be given to the Jano results vs what was done here, it's especially important to structure the test properly.
Most importantly is establishing the level of aggregates at the start and end in both the filtered and unfiltered samples after receiving the same treatment.
Just because some shit UGL formation has a propensity to aggregate quickly could easily be interpreted as "filtering causes aggregation".
It'd be nice to get an MFI particle count. Because it's pretty damn unlikely pharma grade HGH has fewer particles than UGL. Since some will dismiss aggregation as nothing of concern anyway, it's still hard to argue getting the particulate trash of any kind out of what you're injecting is a bad idea.
There is simply no known way low pressure syringe filtration would increase aggregation. It may be my fault for bringing that possibility up to begin with, but it's now clear to me that is a potential issue on the manufacturing line, not one in the hands of a syringe holder.
View attachment 320194